Kim YN - Search Results

1

Identification of annexin II as a novel secretory biomarker for breast cancer.

Jeon YR, Kim SY, Lee EJ, Kim YN, Noh DY, Park SY, Moon A. Jeon YR, et al. Among authors: kim yn, kim sy. Proteomics. 2013 Nov;13(21):3145-56. doi: 10.1002/pmic.201300127. Epub 2013 Sep 24. Proteomics. 2013. PMID: 24019232

2

STAT3-RANTES autocrine signaling is essential for tamoxifen resistance in human breast cancer cells.

Yi EH, Lee CS, Lee JK, Lee YJ, Shin MK, Cho CH, Kang KW, Lee JW, Han W, Noh DY, Kim YN, Cho IH, Ye SK. Yi EH, et al. Among authors: kim yn. Mol Cancer Res. 2013 Jan;11(1):31-42. doi: 10.1158/1541-7786.MCR-12-0217. Epub 2012 Oct 16. Mol Cancer Res. 2013. PMID: 23074171

3

Down-regulation of lipid raft-associated onco-proteins via cholesterol-dependent lipid raft internalization in docosahexaenoic acid-induced apoptosis.

Lee EJ, Yun UJ, Koo KH, Sung JY, Shim J, Ye SK, Hong KM, Kim YN. Lee EJ, et al. Among authors: kim yn. Biochim Biophys Acta. 2014 Jan;1841(1):190-203. doi: 10.1016/j.bbalip.2013.10.006. Epub 2013 Oct 11. Biochim Biophys Acta. 2014. PMID: 24120917

4

Discoidin domain receptor 1 is a novel transcriptional target of ZEB1 in breast epithelial cells undergoing H-Ras-induced epithelial to mesenchymal transition.

Koh M, Woo Y, Valiathan RR, Jung HY, Park SY, Kim YN, Kim HR, Fridman R, Moon A. Koh M, et al. Among authors: kim yn, kim hr. Int J Cancer. 2015 Mar 15;136(6):E508-20. doi: 10.1002/ijc.29154. Epub 2014 Aug 30. Int J Cancer. 2015. PMID: 25155634 Free PMC article.

5

Anti-Tumor Effects of Sodium Meta-Arsenite in Glioblastoma Cells with Higher Akt Activities.

Lee EJ, Sung JY, Koo KH, Park JB, Kim DH, Shim J, Lee CH, Park J, Kim YN. Lee EJ, et al. Among authors: kim dh, kim yn. Int J Mol Sci. 2020 Nov 26;21(23):8982. doi: 10.3390/ijms21238982. Int J Mol Sci. 2020. PMID: 33256086 Free PMC article.

6

Fibronectin regulates anoikis resistance via cell aggregate formation.

Han HJ, Sung JY, Kim SH, Yun UJ, Kim H, Jang EJ, Yoo HE, Hong EK, Goh SH, Moon A, Lee JS, Ye SK, Shim J, Kim YN. Han HJ, et al. Among authors: kim h, kim sh, kim yn. Cancer Lett. 2021 Jun 28;508:59-72. doi: 10.1016/j.canlet.2021.03.011. Epub 2021 Mar 23. Cancer Lett. 2021. PMID: 33771684

7

CK20 expression enhances the invasiveness of tamoxifen-resistant MCF-7 cells.

Min YS, Yi EH, Lee JK, Choi JW, Sim JH, Kang JS, Kim YN, Juhnn YS, Kim HR, Ye SK. Min YS, et al. Among authors: kim yn, kim hr. Anticancer Res. 2012 Apr;32(4):1221-8. Anticancer Res. 2012. PMID: 22493352

8

HSP27 regulates cell adhesion and invasion via modulation of focal adhesion kinase and MMP-2 expression.

Lee JW, Kwak HJ, Lee JJ, Kim YN, Lee JW, Park MJ, Jung SE, Hong SI, Lee JH, Lee JS. Lee JW, et al. Among authors: kim yn. Eur J Cell Biol. 2008 Jun;87(6):377-87. doi: 10.1016/j.ejcb.2008.03.006. Epub 2008 May 9. Eur J Cell Biol. 2008. PMID: 18472181

9

Endothelial cells under therapy-induced senescence secrete CXCL11, which increases aggressiveness of breast cancer cells.

Hwang HJ, Lee YR, Kang D, Lee HC, Seo HR, Ryu JK, Kim YN, Ko YG, Park HJ, Lee JS. Hwang HJ, et al. Among authors: kim yn. Cancer Lett. 2020 Oct 10;490:100-110. doi: 10.1016/j.canlet.2020.06.019. Epub 2020 Jul 11. Cancer Lett. 2020. PMID: 32659248

10

Transcriptional regulation of TNF family receptors and Bcl-2 family by chemotherapeutic agents in murine CT26 cells.

Choi KH, Choi HY, Ko JK, Park SS, Kim YN, Kim CW. Choi KH, et al. Among authors: kim cw, kim yn. J Cell Biochem. 2004 Feb 1;91(2):410-22. doi: 10.1002/jcb.10745. J Cell Biochem. 2004. PMID: 14743399

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

652 results

Search Page

Filters